Skip to content
Clinical Trials – home
PortugalBack to Portugal

Clinical trials in Guilhufe – page 33

694 clinical trials in Guilhufe, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.

PortugalOur site in PortugalEnsaios-Clinicos.pt(opens in a new tab)
Guilhufe at a glance
694
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

694 trials in Guilhufe

Open in trial search

Aplastic anaemia+1

Not recruiting

A study to compare the absorption of eltrombopag olamine in healthy volunteers to ensure the tablets work the same way for patients with thrombocytopenia or aplastic anemia.

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · Healthy volunteers
  • Substances:Eltrombopag olamine
  • Sponsor:Bluepharma Industria Farmaceutica S.A.

Hypogonadism male

Not recruiting

A study to compare the absorption of testosterone transdermal gel in healthy female subjects

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Testosterone
  • Sponsor:Laboratorios Leon Farma S.A.

Nicotine dependence

Not recruiting

A study to evaluate how cytisinicline works in patients with nicotine addiction and kidney problems or those undergoing dialysis

InvestigationalNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Cytisinicline
  • Sponsor:Achieve Life Sciences Inc.

Angelman's syndrome

Not recruiting

A Study Testing the Safety and How Well GTX-102 Works in Adults and Children with Angelman Syndrome

InvestigationalNo placebo
Countries:PortugalPortugal
  • Participants:0–17 years · 18–64 years
  • Substances:Apazunersen
  • Sponsor:Ultragenyx Pharmaceutical Inc.

Pneumonia+1

Not recruiting

A study testing trimodulin in hospitalized adult patients with community-acquired pneumonia including COVID-19 pneumonia

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Trimodulin (Human Igm, Iga, Igg Solution)
  • Sponsor:Biotest GmbH & Co. KGaA

Breast cancer+3

Not recruiting

Study of romiplostim for treating low platelet counts caused by chemotherapy in adults with non-small cell lung cancer, ovarian cancer, or breast cancer

Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Romiplostim
  • Sponsor:Amgen Inc.

Aplastic anaemia+1

Not recruiting

A Study Comparing Eltrombopag Tablets in Healthy Volunteers to Test if Two Forms of the Medicine Work the Same Way in the Body After Taking with Food

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · Healthy volunteers
  • Substances:Eltrombopag olamine
  • Sponsor:Bluepharma Industria Farmaceutica S.A.

Endometrial cancer+2

Not recruiting

A study comparing how lenvatinib capsules are absorbed in the body in healthy volunteers under fasting and fed conditions

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · Healthy volunteers
  • Substances:Lenvatinib
  • Sponsor:Bluepharma Industria Farmaceutica S.A.

A study testing tozorakimab for long-term treatment of chronic obstructive pulmonary disease in former smokers with repeated flare-ups

Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:AstraZeneca AB

Dermatomyositis

Not recruiting

A study testing brepocitinib compared to placebo for adults with dermatomyositis to see if it works and is safe

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Brepocitinib Tosilate
  • Sponsor:Priovant Therapeutics Inc.

Study of Tozorakimab for Patients with Chronic Obstructive Pulmonary Disease Who Have Symptoms and a History of Flare-ups

Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol Sulfate
  • Sponsor:AstraZeneca AB

A study comparing 4D-150 and aflibercept for adults with abnormal blood vessel growth in the eye due to age-related macular degeneration

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:4d Molecular Therapeutics Inc.

Other cities in Portugal

The busiest research cities in the country

All 48 cities in Portugal

Clinical research in Guilhufe

What the registry says about research in the country

01 Autoimmune Disorders

Innovative research focusing on Systemic Lupus Erythematosus (SLE) treatment evaluation, examining new therapeutic approaches for patients with moderate to severe manifestations of the disease.

  • Disease management strategies
  • Long-term safety assessment
  • Treatment efficacy evaluation

Studies aim to advance understanding of treatment responses in adults with active SLE despite ongoing therapy.

02 Cardiovascular Medicine

Advanced clinical research investigating stroke prevention in patients with atrial fibrillation, comparing innovative anticoagulation approaches.

  • Stroke prevention strategies
  • Bleeding risk assessment
  • Systemic embolism prevention

Comparative studies evaluating treatment efficacy and safety profiles in cardiac patients.

03 Infectious Diseases

Observational research examining mpox virus disease outcomes and treatment effectiveness, with particular focus on antiviral interventions.

  • Clinical outcome analysis
  • Antiviral treatment evaluation
  • Disease progression monitoring

Research aims to enhance understanding of treatment responses in infected patients.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.